Most non-compliant hair restoration copy is not written by someone trying to cut a corner. It is written by a competent copywriter who has never been told that "scarless" is a prohibited claim, that "your thinning hair" is a policy violation, or that "FDA-approved" describes a thing the FDA does not do to procedures.
This is a working reference for that person. Roughly forty phrases, the compliant version of each, and the reason the replacement is usually the stronger line rather than the weaker one.
One principle underneath all of it. Four authorities reach this copy: your professional society, the FTC, the FDA, and the ad platforms, plus your state medical board. Write to the strictest of them and you clear all of them at once. Writing to Google's line alone leaves you exposed to the three that can affect your license.
Category 1: Scarring and invasiveness
FUE reduces linear scarring compared to strip harvesting. It does not eliminate scarring. Every extraction site is a wound that heals as a small dot scar. Describing FUE as scar-free misrepresents the procedure to a person making a medical decision, which is why the professional standards treat it as false advertising rather than as enthusiasm.
| Do not write | Write instead |
|---|---|
| Scarless hair restoration | FUE minimizes visible linear scarring compared with strip harvesting |
| No incisions, no scars | Extraction sites heal as small dot scars that are typically not visible with short hair |
| Leaves no trace | Designed to leave minimal visible evidence of the procedure |
| Non-invasive hair restoration | Minimally invasive follicular unit extraction |
| Non-surgical FUE | FUE is a surgical procedure performed under local anesthetic |
That last pair matters more than it looks. Calling a procedure with extractions and implantation non-surgical is the mischaracterization professional bodies name specifically, and it is also the one most likely to surface in a patient dispute.
Category 2: Pain and downtime
Absolute claims about pain and recovery are false for some patient somewhere, which is all the FTC requires, and they generate bad reviews from the patients who believed them.
| Do not write | Write instead |
|---|---|
| Painless procedure | Performed under local anesthetic. Most patients describe the procedure itself as comfortable |
| No pain, no downtime | Most patients return to non-strenuous activity within a few days. Your physician will review recovery with you |
| Zero recovery time | Recovery varies. Expect specific aftercare instructions and activity limits |
| Walk in, walk out, back to work tomorrow | Many patients resume desk work quickly. Timelines vary by case |
"Most patients" is doing real work in these. It is a characterization of a distribution rather than a promise to the reader, and it is defensible if your practice can actually describe that distribution.
Category 3: Outcomes and guarantees
Graft survival, density, and growth timelines vary by patient, donor supply, technique, and aftercare. No reputable surgeon guarantees an outcome, and copy that does is the single clearest FTC substantiation problem in the vertical.
| Do not write | Write instead |
|---|---|
| Guaranteed regrowth | Your physician will review what is realistic for your donor supply and goals |
| 100% success rate | Ask about outcomes for cases similar to yours during your evaluation |
| Permanent results guaranteed | Transplanted follicles are typically resistant to the pattern that caused the original loss |
| A full head of hair | Improved coverage in the treated area, based on your candidacy |
| Restore your hairline completely | Hairline design is planned with your physician based on donor density and facial proportion |
| Natural results, every time | Hairline design and graft placement are planned to look natural in your case |
Note the last one. "Natural-looking results" is not banned language, but as an unqualified promise applied to everyone it is a typical-outcome claim, and the FTC's current standard on before-and-after material asks what typical actually is.
Category 4: Donor supply and graft counts
| Do not write | Write instead |
|---|---|
| Unlimited grafts | Your donor area is assessed during consultation to determine available grafts |
| As many grafts as you need | Graft planning depends on your donor density and the area being treated |
| Hair cloning available now | Hair multiplication remains in research and is not clinically available |
| Hair multiplication | Current donor management techniques will be reviewed with your physician |
| We can treat any degree of hair loss | Candidacy depends on your pattern, donor supply, and goals |
Cloning and multiplication are not merely overstatements. Marketing them as an available service is simultaneously a false advertising violation and an off-label promotion risk, because the underlying techniques have no regulatory clearance for general clinical use.
Category 5: Addressing the reader
This is the category that produces the most ad disapprovals and the one practices find hardest to believe, because the offending copy sounds sympathetic.
Two separate rules are in play. Platforms prohibit negativity about physical attributes. They separately prohibit copy that assumes the reader has the condition.
| Do not write | Write instead |
|---|---|
| Tired of hiding your thinning hair? | Hair loss evaluation with a board-certified physician |
| Embarrassed by your hairline? | Understand what is causing hair loss and which options fit |
| Are you suffering from hair loss? | Medical evaluation for hair loss, in [city] |
| Don't let hair loss hold you back | Book a hair loss assessment |
| Reclaim your confidence | Talk to a hair loss specialist about your options |
| Look years younger | Hair restoration consultation with Dr. [Name] |
| Your hair loss, solved | Hair loss treatment options, explained in a consultation |
| Your receding hairline | Receding hairlines: what causes them and what can be done |
The pattern across the whole right column: describe the service, the physician, or the condition in general terms. Never describe the reader's body back to them. It costs nothing, and the replacement lines routinely outperform, because a person researching a five-figure medical decision responds better to competence than to being told how they feel about themselves.
Category 6: Regulatory and device language
| Do not write | Write instead |
|---|---|
| FDA-approved FUE procedure | The FDA clears devices, not surgical techniques. Remove the claim |
| FDA-approved ARTAS | Using the FDA-cleared ARTAS system |
| FDA-approved hair transplant | Performed by a board-certified physician using FDA-cleared instrumentation |
| ARTAS® robotic system | ARTAS robotic system (never a trademark symbol in ad copy) |
| Certified NeoGraft provider | Only if documented authorized-provider status exists for that manufacturer |
Two distinctions carry most of the risk here. Cleared and approved are different regulatory facts, and using the stronger word for a device that only holds the weaker one is a false claim, not a rounding error. And authorization is per manufacturer: a document covering ARTAS and NeoGraft, both Venus Concept, does not cover Alma TED, which belongs to Alma Lasers.
Also worth separating two facts that get conflated constantly. A practice owner confirming they own a device establishes that they offer it. It does not establish documented authorized-provider status, which is the thing that makes the trademark usable in an ad.
Category 7: Medications
Finasteride and minoxidil may be referenced non-promotionally in ads and on landing pages without certification in the US. Keyword-targeting those terms requires healthcare certification. Promotional language requires pharmaceutical manufacturer certification.
| Do not write | Write instead |
|---|---|
| Get your finasteride prescription here | Medical hair loss programs, including prescription options where appropriate |
| Buy Propecia online | Medication options are discussed during your medical evaluation |
| Finasteride for women | Off-label use cannot be advertised. Remove |
That last row is the one that surprises physicians. A doctor may lawfully prescribe off-label. Advertising the off-label indication is a separate act and is not permitted.
How to use this without turning your copy into a disclaimer
The right column is not a set of hedges. Read it again and notice what it actually does: it moves every line from a promise about a result to a statement about the evaluation, the physician, and the process. That is a stronger sales position in a five-figure elective category, because the thing you are genuinely selling on the first click is the consultation.
Three working rules:
- Run every asset against this list before publication, across the whole digital presence. Professional advertising standards reach your website, your social accounts, your business profile description, and your press releases, not only your paid ads.
- Audit the composite, not the line. A compliant headline over an image implying a complete transformation can still fail the FTC's net impression test. Read the page as a stranger would.
- Fix the source, not the instance. A phrase in a page template appears on forty pages. Fixing the one you found does not fix the other thirty-nine.
For the Google-specific mechanics behind several of these, see our Google Ads policy guide for hair restoration practices. For how all the regimes stack and which one governs which claim, see our hair transplant marketing compliance guide.
This guide is a practical reference, not legal advice, and both policy language and enforcement change. Verify against current sources before you rely on any specific line.
See where your own growth leaks.
The free Practice Growth Audit traces your demand, your follow-through and your measurement, and hands you the gaps in writing. Built by hand, yours to keep.
